Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 4
Journal homepage
81
Views
47
CrossRef citations to date
0
Altmetric
Case Report

Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren’s syndrome

Daisuke WakasugiDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Takashi KatoDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Takahisa GonoDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Eiichi ItoDepartment of Neurology, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
,
Hiroyuki NoderaDepartment of Neurology, The University of Tokushima, 3-8-15 Kuramoto-cho, Tokushima 770-8503, Japan
,
Yasushi KawaguchiDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, JapanCorrespondence[email protected]
,
Hisashi YamanakaDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
&
Masako HaraDepartment of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
 show all
Pages 437-440 | Received 26 Jan 2009, Accepted 07 Apr 2009, Published online: 02 Jan 2014

References

  • Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjögren syndrome-associated neuropathy. Brain. 2005;128:2518–34.
  • Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve. 2003;28:553–60.
  • Hoitsma E, Reulen JP, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disor-der. J Neurol Sci. 2004;227:119–30.
  • Al-Shekhlee A, Chelimsky TC, Preston DC. Review: small-fiber neuropathy. Neurologist. 2002;8:237–53.
  • Chai J, Herrmann DN, Stanton M, Barbano RL, Loqiqian EL. Painful small-fiber neuropathy in Sjögren syndrome. Neurology. 2005;65:925–7.
  • Vitali C, Bambardieri S, Jonsson R, Moutsopoulos HM, Alex-ander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American—European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
  • Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellqren SI, Omdal R. Peripheral neuropathy in primary Sjögren's syn-drome. A population-based study. Arch Neurol. 2006;63:1612–5.
  • Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren's syndrome. A study of 82 patients. Medicine (Baltimore). 2004; 83:280–91.
  • Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuropathy with Sjögren's syndrome. Neurology. 2003;60:503–5.
  • Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neu-ropathy without sensory ataxia associated with Sjögren syn-drome. J Neurol Neurosurg Psychiatry. 2006;77:967–9.
  • Levy Y, Uziel Y, Zandman GG, Amital H, Sherer Y, Langevitz P, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221–3.
  • van Doom PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1990;29:57–64.
  • Saoudi A, Hurez V, de Kozak Y, Huhn J, Kaveri SV, Kazatchine MD, et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol. 1990;5:1559–67.
  • Anderson CL. Human IgG Fc receptor. Clin Immunol Immuno-pathol. 1989;53:S63–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.